Julia Novak

from Everett, WA

Get Report

Also known as:

Julia K Sobolenko

Connected to:

Julia Novak Phones & Addresses

Everett, WA
Lynnwood, WA

Resumes

Julia Novak

view source

Vp Of Research And Project Management At Blaze Bioscience, Inc.

view source

Location:

Greater Seattle Area

Industry:

Biotechnology

Name / Title

Company / Classification

Phones & Addresses

Julia D Novak

THE NOVAK CONSULTING GROUP, INC

Us Patents

Nucleic Acid Which Encodes The Tumor Marker Zsig62
view source
US Patent:

6403783, Jun 11, 2002
Filed:

Jan 18, 2000
Appl. No.:

09/493565
Inventors:

Paul O. Sheppard - Granite Falls WA
Julia E. Novak - Bainbridge Island WA
Fenella Raymond - Seattle WA
Assignee:

ZymoGenetics, Inc. - Seattle WA
International Classification:

C07H 2104
US Classification:

536 235, 536 231, 4353201, 435 691, 435325, 435348, 435349, 435410, 4352541, 4352542
Abstract:

Studies indicate that mutations in tumor suppressor genes occur early in the process of carcinogenesis, and that these mutations are correlated with a subsequent development of cancer. The detection of such alterations would provide useful molecular markers for diagnosis, surveillance, early tumor identification and intervention, and prognosis. A novel human gene, designated as âZsig62,â resides within a region of chromosome 16 that is associated with prostate and breast cancer, and that appears to contain tumor suppressor genes. Like a tumor suppressor gene, the Zsig62 gene is expressed in particular normal tissues, but not in tumors derived from those tissues.

Methods For Promoting Production Of Myelin By Schwann Cells
view source
US Patent:

6569419, May 27, 2003
Filed:

Feb 27, 2001
Appl. No.:

09/794705
Inventors:

Emma E. Moore - Seattle WA
Julia E. Novak - Bainbridge Island WA
Assignee:

ZymoGenetics, Inc. - Seattle WA
International Classification:

A61K 3819
US Classification:

424 851, 514 2, 514 8, 514 12
Abstract:

A method for promoting the expression of myelin or Protein Zero in Schwann cells using Zcyto7 or IL-17. Zcyto7 or IL-17 are further used to promote myelination of the peripheral nervous system. This is particularly useful in treating diseases dymyelinating diseases such as diabetic neuropathy, Guillain-BarrÃ Syndrome, chronic demyelinating disease, acute demyelinating polyneuropathy and human immunodeficiency viral demyelinating neuropathy or demyelination caused by trauma.

Methods Of Using Zalpha11 Ligand
view source
US Patent:

6605272, Aug 12, 2003
Filed:

Aug 3, 2001
Appl. No.:

09/923246
Inventors:

Julia E. Novak - Bainbridge Island WA
Scott R. Presnell - Tacoma WA
Cindy A. Sprecher - Seattle WA
Donald C. Foster - Lake Forest Park WA
Richard D. Holly - Seattle WA
Jane A. Gross - Seattle WA
Janet V. Johnston - Seattle WA
Andrew J. Nelson - Shoreline WA
Stacey R. Dillon - Seattle WA
Angela K. Hammond - Maple Valley WA
Assignee:

ZymoGenetics, Inc. - Seattle WA
International Classification:

A61K 4500
US Classification:

424 852, 424 851, 4241691, 4241731, 4241741, 514 2, 514 12
Abstract:

The present invention relates to zalpha11 Ligand polynucleotide and polypeptide molecules. The zalpha11 Ligand is a novel cytokine. The polypeptides may be used within methods for stimulating the proliferation and/or development of hematopoietic cells in vitro and in vivo. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.

Cytokine Zalpha11 Ligand Polynucleotides
view source
US Patent:

6686178, Feb 3, 2004
Filed:

Nov 15, 2002
Appl. No.:

10/295723
Inventors:

Julia E. Novak - Bainbridge Island WA
Scott R. Presnell - Tacoma WA
Cindy A. Sprecher - Seattle WA
Donald C. Foster - Lake Forest Park WA
Richard D. Holly - Seattle WA
Jane A. Gross - Seattle WA
Janet V. Johnston - Seattle WA
Andrew J. Nelson - Shoreline WA
Stacey R. Dillon - Seattle WA
Angela K. Hammond - Maple Valley WA
Assignee:

ZymoGenetics, Inc. - Seattle WA
International Classification:

C12N 1524
US Classification:

435 6952, 435 691, 435 701, 4353201, 435325, 4241301, 4241431, 536 231, 536 241
Abstract:

The present invention relates to zalpha11 Ligand polynucleotide and polypeptide molecules. The zalpha11 Ligand is a novel cytokine. The polypeptides may be used within methods for stimulating the proliferation and/or development of hematopoietic cells in vitro and in vivo. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.

Soluble Zalpha11 Cytokine Receptors
view source
US Patent:

6777539, Aug 17, 2004
Filed:

Apr 3, 2001
Appl. No.:

09/825561
Inventors:

Cindy A. Sprecher - Seattle WA
Julia E. Novak - Bainbridge Island WA
James W. West - Seattle WA
Scott R. Presnell - Tacoma WA
Richard D. Holly - Seattle WA
Andrew J. Nelson - Shoreline WA
Assignee:

ZymoGenetics, Inc. - Seattle WA
International Classification:

C07K 14435
US Classification:

530350, 530351
Abstract:

Novel polypeptide combinations, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for soluble zalpha11 receptors that may be used as novel cytokine antagonists, and within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. Ligand-binding receptor polypeptides can also be used to block zlapha11 Ligand activity in vitro and in vivo, and may be used in conjunction with zalpha11 Ligand and other cytokines to selectively stimulate the immune system. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.

Soluble Zalpha11 Cytokine Receptors
view source
US Patent:

7189695, Mar 13, 2007
Filed:

Jun 18, 2004
Appl. No.:

10/872087
Inventors:

Cindy A. Sprecher - Seattle WA, US
Julia E. Novak - Bainbridge Island WA, US
James W. West - Seattle WA, US
Richard D. Holly - Seattle WA, US
Andrew J. Nelson - Shoreline WA, US
Assignee:

ZymoGenetics, Inc. - Seattle WA
International Classification:

A61K 38/17
C07K 14/435
US Classification:

514 12, 530350
Abstract:

Novel polypeptide combinations, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for soluble zalpha11 receptors that may be used as novel cytokine antagonists, and within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. Ligand-binding receptor polypeptides can also be used to block zlapha11 Ligand activity in vitro and in vivo, and may be used in conjunction with zalpha11 Ligand and other cytokines to selectively stimulate the immune system. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.

Umlr Polypeptides
view source
US Patent:

7217790, May 15, 2007
Filed:

Sep 12, 2003
Appl. No.:

10/660968
Inventors:

Wenfeng Xu - Mukilteo WA, US
Randal M. Henne - Seattle WA, US
Scott R. Presnell - Tacoma WA, US
Yue Yao - Kenmore WA, US
Julia E. Novak - Bainbridge Island WA, US
Assignee:

ZymoGenetics, Inc. - Seattle WA
International Classification:

C07K 14/00
US Classification:

530350, 536 235
Abstract:

Novel secreted and membrane bound tumor necrosis factor receptor (TNFR) polypeptides, polynucleotides encoding the polypeptides, antibodies and related compositions and methods are disclosed. The polypeptides may be used for detecting ligands, agonists and antagonists. The polypeptides, polynucleotides and antibodies may also be used in methods that modulate inflammation, tumor growth and metastasis, infection, immunity, and cellular maturation.

Methods Of Using Cytokine Receptor Zalpha11 To Detect Its Ligands
view source
US Patent:

7435550, Oct 14, 2008
Filed:

Jun 9, 2004
Appl. No.:

10/864249
Inventors:

Julia E. Novak - Bainbridge Island WA, US
Angela K. Hammond - Maple Valley WA, US
Assignee:

ZymoGenetics, Inc. - Seattle WA
International Classification:

G01N 33/53
G01N 33/531
G01N 33/532
C07K 14/00
C07K 14/52
US Classification:

435 71, 435 72, 435 697, 530350, 530351
Abstract:

Novel polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for zalpha11, a novel cytokine receptor. The polypeptides may be used within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. Ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo. The polynucleotides encoding zalpha11, are located on chromosome 16, and can be used to identify a region of the genome associated with human disease states. The present invention also includes methods for producing the protein, uses therefore and antibodies thereto.

News

Harrisburg Council Rejects Pa. State Financial Fix

view source

The Harrisburg Regional Chamber and Dauphin County, which includes Harrisburg, both supported the state's plan. One of the state's consultants, Cincinnati-based Julia Novak, said the team worked to extract some concessions from the county and bond insurer Assured Guaranty Municipal Corp., which have
Date: Jul 19, 2011
Category: Business
Source: Google

Myspace

Julia Novak

view source

Locality:

Callliiiffoorrnniiaa:)

Gender:

Female

Birthday:

1951

Julia Novak

view source

Locality:

Swietokrzyskie, Poland

Gender:

Female

Birthday:

1946

Youtube

Vocal Coach Reacts to KZ Tandingan - ROLLING ...

/Vocal coach/Singer/Son... reacts to KZ Tandigan - Rolling in the dee...

Duration:

7m 34s

VOCAL COACH Juliett Novak REACTS - MARCELITO ...

We're still not sure if he did all by himself or had some 'female help...

Duration:

4m 56s

VOCAL COACH reacts to MORISSETTE AMON - 'Akin...

/ Singer- songwriter/ Musician / Voice coach reacts to Morissette. Voc...

Duration:

7m 3s

Vocal Coach Juliett Reacts to Marcelito Pomoy...

VOICE LESSONS with Juliett? E-mail : juliettmusic.off... JULIETT INST...

Duration:

7m 56s

Julia Novak, Psychic Medium: 'Those feelings ...

In this episode, Alexandra chats to Psychic Medium, author and Alchymy...

Duration:

24m 21s

VOCAL COACH REACTS to MARCELITO POMOY - The P...

VOICE LESSONS with Juliett? E-mail : juliettmusic.off... JULIETT INST...

Duration:

6m 29s

Facebook

Julia Novak

view source

Julia Novak

view source

Julia Novak

view source

Julia Novak

view source

Julia Novak

view source

Julia Novak

view source

Julia Novak

view source

Julia Novak

view source

Plaxo

Julia Novak

view source

SF Bay AreaIntuitive & Feng Shui Consultant, Writer at Indepe... I use my practical intuitive ability to read energy - of people, places, and events - helping clients focus on personal and professional strengths, creativity... I use my practical intuitive ability to read energy - of people, places, and events - helping clients focus on personal and professional strengths, creativity, and finding joy. Career readings particularly focus on meaningful life's work, business development, and personnel/partnership issues. I ...